EU post-market surveillance and QP role among list of Council’s big changes to be mulled
This article was originally published in Clinica
The burden on medtech manufacturers to follow up the quality, performance and safety of their devices that are on the market could get heavier, if proposals by the Council of the EU for the forthcoming Medical Device Regulation are to go ahead.
You may also be interested in...
The UK is taking measures to increase its ventilator stock from 8,000 to some 30,000, but it will take time to make them available. Many are asking whether the government really rejected EU help, which could have brought relief sooner, because of Brexit.
How to get non-CE-marked medical devices onto the UK market at speed
Manufacturers normally must pay to access medtech and personal protective equipment standards. But now some are freely available in the EU.